Clario is an acquired company based in Philadelphia (United States), founded in 1972. It operates as a CRO focused on providing clinical trial supply services for biopharma sector. Clario has raised an undisclosed amount in funding. The company has 214 active competitors, including 13 funded and 13 that have exited. Its top competitor s include companies like CRYOPDP, SFJ Pharmaceuticals and N ...
Clario Medical Imaging is an acqui-hired company based in Seattle (United States), founded in 2005. It operates as a Workflow and practice management software solutions for radiologists. Clario Medical Imaging has raised $7.7M in funding. The company has 192 active competitors, including 19 funded and 17 that have exited. Its top competitor s include companies like Intelerad, Sirona Medical ...
Clario has raised funding over 1 round from 9 investors. Investors include ATP Private Equity Partners, Athyrium Capital Management and 7 others. Their latest funding round was of $699K on .
Discover Clario's complete list of acquisitions with year-wise trends, sector-wise breakdowns, geographic insights, and related M&A news and activity data.
Clario is a provider of customer-centric marketing optimization solutions for businesses. Its features include holistic customer data integration - it integrates customer data from all sources like a social, marketplace, etc, predicted customer lifetime value (CLV), customer behavior modeling, automated audience activation, and more.
Thermo Fisher Scientific has made 54 acquisitions across sectors such as Life Sciences Platforms and Tools, Genomics, Biopharma Outsourcing and others. Clario, Olink and CorEvitas are its latest acquisitions.
iCardiac Technologies - Company offering core laboratory services mainly for cardiac safety testing and respiratory diseases. Acquired by Clario. Raised a total funding of $4M over 3 rounds from 6 investors.